MedTrace Logo

Left Ventricular Stiffness vs. Fibrosis Quantification by T1 Mapping in Heart Failure With Preserved Ejection Fraction

NCT02459626 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2021-05-10

No results posted yet for this study

Summary

StiffMAP-HFpEF trial is an investigator initiated, observational, single-center study that will evaluate whether fibrosis quantification by cardiac MRI correlates with left and right ventricular stiffness derived from pressure-volume analysis, aiming to clarify if cardiac MRI is a valid, non-invasive method to assess diastolic function in patients with Heart Failure with preserved ejection fraction.

Conditions

  • Heart Failure With Normal Ejection Fraction

Interventions

OTHER

Diagnostic P-V-loops and MRI

Invasive assessment of P-V-loops during catheterization for suspected CAD Magnetic resonance Imaging for assessment of myocardial fibrosis and biventricular function

Sponsors & Collaborators

  • Heart Center Leipzig - University Hospital

    lead OTHER

Principal Investigators

  • Philipp Lurz, PhD · University Heart Center Leipzig

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-05-31
Completion
2018-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02459626 on ClinicalTrials.gov